Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 13 (3), 172-83

Drosophila Melanogaster: A Model and a Tool to Investigate Malignancy and Identify New Therapeutics

Affiliations
Review

Drosophila Melanogaster: A Model and a Tool to Investigate Malignancy and Identify New Therapeutics

Cayetano Gonzalez. Nat Rev Cancer.

Abstract

For decades, lower-model organisms such as Drosophila melanogaster have often provided the first glimpse into the mechanism of action of human cancer-related proteins, thus making a substantial contribution to elucidating the molecular basis of the disease. More recently, D. melanogaster strains that are engineered to recapitulate key aspects of specific types of human cancer have been paving the way for the future role of this 'workhorse' of biomedical research, helping to further investigate the process of malignancy, and serving as platforms for therapeutic drug discovery.

Similar articles

See all similar articles

Cited by 92 articles

See all "Cited by" articles

References

    1. Nat Rev Mol Cell Biol. 2009 Apr;10(4):265-75 - PubMed
    1. Genes Dev. 2010 Oct 15;24(20):2294-302 - PubMed
    1. Nat Genet. 2005 Oct;37(10):1125-9 - PubMed
    1. Mol Cancer Ther. 2008 Sep;7(9):2672-80 - PubMed
    1. Dis Model Mech. 2011 Nov;4(6):753-61 - PubMed

Publication types

LinkOut - more resources

Feedback